vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与RADWARE LTD（RDWR）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是RADWARE LTD的1.0倍（$75.5M vs $75.3M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 7.1%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
拉德韦尔是一家为物理、云与软件定义数据中心提供网络安全与应用交付产品的企业，总部位于美国新泽西州莫瓦，全球总部设于以色列，同时在欧洲、非洲及亚太地区均设有办事处，隶属于拉德集团，股份在纳斯达克上市交易。
PBYI vs RDWR — 直观对比
营收规模更大
PBYI
是对方的1.0倍
$75.3M
两年增速更快
PBYI
近两年复合增速
7.1%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $75.3M |
| 净利润 | — | $5.7M |
| 毛利率 | 69.3% | 80.7% |
| 营业利润率 | 22.7% | 4.1% |
| 净利率 | — | 7.5% |
| 营收同比 | 27.7% | — |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.26 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIRDWR
| Q4 25 | $75.5M | — | ||
| Q3 25 | $54.5M | $75.3M | ||
| Q2 25 | $52.4M | $74.2M | ||
| Q1 25 | $46.0M | $72.1M | ||
| Q4 24 | $59.1M | — | ||
| Q3 24 | $80.5M | $69.5M | ||
| Q2 24 | $47.1M | $67.3M | ||
| Q1 24 | $43.8M | $65.1M |
净利润PBYIRDWR
| Q4 25 | — | — | ||
| Q3 25 | $8.8M | $5.7M | ||
| Q2 25 | $5.9M | $4.2M | ||
| Q1 25 | $3.0M | $4.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | $20.3M | $3.1M | ||
| Q2 24 | $-4.5M | $1.7M | ||
| Q1 24 | $-4.8M | $-1.2M |
毛利率PBYIRDWR
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | 80.7% | ||
| Q2 25 | 76.5% | 80.7% | ||
| Q1 25 | 77.1% | 80.6% | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | 80.7% | ||
| Q2 24 | 77.4% | 80.6% | ||
| Q1 24 | 75.5% | 80.3% |
营业利润率PBYIRDWR
| Q4 25 | 22.7% | — | ||
| Q3 25 | 17.6% | 4.1% | ||
| Q2 25 | 12.7% | 3.8% | ||
| Q1 25 | 8.7% | 2.2% | ||
| Q4 24 | 22.6% | — | ||
| Q3 24 | 27.4% | -0.0% | ||
| Q2 24 | -4.6% | -1.8% | ||
| Q1 24 | -5.3% | -5.6% |
净利率PBYIRDWR
| Q4 25 | — | — | ||
| Q3 25 | 16.2% | 7.5% | ||
| Q2 25 | 11.2% | 5.7% | ||
| Q1 25 | 6.5% | 6.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.2% | 4.5% | ||
| Q2 24 | -9.6% | 2.5% | ||
| Q1 24 | -11.0% | -1.9% |
每股收益（稀释后）PBYIRDWR
| Q4 25 | $0.26 | — | ||
| Q3 25 | $0.17 | — | ||
| Q2 25 | $0.12 | — | ||
| Q1 25 | $0.06 | — | ||
| Q4 24 | $0.40 | — | ||
| Q3 24 | $0.41 | — | ||
| Q2 24 | $-0.09 | — | ||
| Q1 24 | $-0.10 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $98.7M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $357.1M |
| 总资产 | $216.3M | $618.7M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYIRDWR
| Q4 25 | $97.5M | — | ||
| Q3 25 | $94.4M | $98.7M | ||
| Q2 25 | $96.0M | $98.7M | ||
| Q1 25 | $93.2M | $98.7M | ||
| Q4 24 | $101.0M | — | ||
| Q3 24 | $96.7M | $70.5M | ||
| Q2 24 | $96.8M | $70.5M | ||
| Q1 24 | $107.2M | $70.5M |
总债务PBYIRDWR
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYIRDWR
| Q4 25 | $130.3M | — | ||
| Q3 25 | $115.3M | $357.1M | ||
| Q2 25 | $104.7M | $357.1M | ||
| Q1 25 | $97.1M | $357.1M | ||
| Q4 24 | $92.1M | — | ||
| Q3 24 | $71.1M | $323.3M | ||
| Q2 24 | $48.5M | $323.3M | ||
| Q1 24 | $51.0M | $323.3M |
总资产PBYIRDWR
| Q4 25 | $216.3M | — | ||
| Q3 25 | $202.9M | $618.7M | ||
| Q2 25 | $194.9M | $618.7M | ||
| Q1 25 | $196.2M | $618.7M | ||
| Q4 24 | $213.3M | — | ||
| Q3 24 | $220.7M | $571.9M | ||
| Q2 24 | $205.0M | $571.9M | ||
| Q1 24 | $214.1M | $571.9M |
负债/权益比PBYIRDWR
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | — |
| 自由现金流经营现金流 - 资本支出 | $14.4M | — |
| 自由现金流率自由现金流/营收 | 19.1% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | — |
8季度趋势，按日历期对齐
经营现金流PBYIRDWR
| Q4 25 | $14.4M | — | ||
| Q3 25 | $9.7M | — | ||
| Q2 25 | $14.1M | $14.5M | ||
| Q1 25 | $3.6M | $22.4M | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $11.0M | — | ||
| Q2 24 | $1.0M | $23.0M | ||
| Q1 24 | $11.2M | — |
自由现金流PBYIRDWR
| Q4 25 | $14.4M | — | ||
| Q3 25 | $9.7M | — | ||
| Q2 25 | $14.1M | $11.8M | ||
| Q1 25 | $3.6M | $21.3M | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $11.0M | — | ||
| Q2 24 | $1.0M | $22.0M | ||
| Q1 24 | — | — |
自由现金流率PBYIRDWR
| Q4 25 | 19.1% | — | ||
| Q3 25 | 17.7% | — | ||
| Q2 25 | 26.8% | 15.9% | ||
| Q1 25 | 7.7% | 29.6% | ||
| Q4 24 | 26.4% | — | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 2.1% | 32.7% | ||
| Q1 24 | — | — |
资本支出强度PBYIRDWR
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | 3.6% | ||
| Q1 25 | 0.1% | 1.5% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | 1.5% | ||
| Q1 24 | 0.0% | — |
现金转化率PBYIRDWR
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | 3.43× | ||
| Q1 25 | 1.21× | 5.17× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | 13.84× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
